![]() In the Physician Fee Schedule final rule for calendar year 2008, CMS established a process for revising the list of compendia, as authorized under section 1861(t)(2) of the Act, and also established a definition for "compendium." See 72 Fed. Consequently, CMS received requests from the stakeholder community for a process to revise the list of compendia. Law 109-171, recognized three compendia: American Medical Association Drug Evaluations (AMA-DE), United States Pharmacopoeia-Drug Information (USP-DI) or its successor publication and American Hospital Formulary Service-Drug Information (AHFS-DI) as authoritative sources for use in the determination of a "medically-accepted indication" of drugs and biologicals used off-label in an anticancer chemotherapeutic regimen, unless the Secretary has determined that the use is not medically appropriate or the use is identified as not indicated in one or more such compendia.ĭue to changes in the pharmaceutical reference industry, fewer of these statutorily-named compendia are available for our reference (e.g., the AMA- DE and the USP-DI are no longer published). Section 1861(t)(2)(B)(ii)(I) of the Social Security Act (the Act), as amended by Section 6001 (f)(1) of the Deficit Reduction Act of 2005, Pub. Indication for the off-label uses of drugs and biologicals in an anticancer chemotherapeutic regimen Subject: Wolters Kluwer Lexi-Drugs® - Request for addition to the list of compendia for the identification of a medically accepted Lead Medical Officer(s): James Rollins, MD, MSHA, PhDĭeputy Director, Coverage and Analysis Group Lead Analyst(s) Cheryl Gilbreath, PharmD, MBA, RPh Requestor Name(s): Wolters Kluwer Clinical Drug Informationįormal Request Accepted and Review Initiated: April 21, 2015Įxpected Completion Date: August 19, 2015 We are very excited to now be a part of the industry’s most complete marketing cloud solution, giving us a global stage to deliver innovative content marketing solutions.The Social Security Act Section 1861(t)(2)(B)(ii)(I) recognizes the following compendia: American Hospital Formulary Service-Drug Information (AHFS-DI), Truven Health Analytics Micromedex DrugDEX (DrugDEX), National Comprehensive Cancer Network (NCCN) Drugs and Biologics Compendium, and Elsevier/Gold Standard Clinical Pharmacology for use in the determination of medically-accepted indications of drugs/biologicals used off-label in anti-cancer chemotherapeutic regimens.ĬMS received a timely complete request for the addition of the Wolters Kluwer Clinical Drug Information Lexi-Drugs database to the list of compendia for use in the determination of medically-accepted indications of drugs/biologicals used off-label in anti-cancer chemotherapeutic regimens. “By combining this buyer profile with Compendium’s data-driven content marketing platform, marketers will be able to deliver the right content, to the right individual across the right channel at the right time. “Oracle Eloqua Marketing Cloud is uniquely positioned to capture a prospect’s digital body language to help companies know each buyer’s demographics, behaviors and influencers,” said Chris Baggott, Compendium CEO. ![]() “By adding Compendium’s content marketing platform to Oracle Eloqua Marketing Cloud, customers will be able to capture more prospects, improve the customer experience and drive top line revenue.” Now, more than ever, marketers are challenged to deliver relevant and engaging content across multiple channels and throughout the customer lifecycle,” said Thomas Kurian, Executive Vice President, Oracle Development. “As customers increasingly access information through online and mobile channels, the buying process is shifting from sales-driven to marketing-driven. More information on this announcement can be found at. ![]() The combination of Oracle Eloqua Marketing Cloud with Compendium is expected to enable modern marketers to align persona-based content to customers’ digital body language to increase “top-of-funnel” customer engagement, improve the quality of sales leads, realize the highest return on their marketing investment, and increase customer loyalty. Oracle today announced that it has acquired Compendium, a cloud-based content marketing provider that helps companies plan, produce and deliver engaging content across multiple channels throughout their customers’ lifecycle.Ĭompendium’s data-driven approach aligns relevant content with customer data and profiles to help companies more effectively attract prospects, engage buyers, accelerate conversion of prospects to opportunities, increase adoption, and drive revenue growth.Ĭompendium’s innovative solution complements Oracle’s industry leading Eloqua Marketing Cloud which is a part of Oracle’s comprehensive Customer Experience solution. ![]()
0 Comments
Leave a Reply. |